DOCSLIB.ORG

UCSF Neurological Surgery 2019 Annual Report Contents

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
UCSF Neurological Surgery 2019 Annual Report Contents UCSF Neurological Surgery 2019 Annual Report Contents 3 Brain Tumor Center Department of Neurological Surgery 20 California Center for University of California, Pituitary Disorders San Francisco 505 Parnassus Ave 22 Brain and Spinal Injury Center Room M779 Dear Colleague: San Francisco, CA 25 Neurospinal Disorders 94143-0112 Phone: (415) 353-7500 I am thrilled to be sharing some of the clinical and research highlights from 28 Vascular Neurosurgery Fax: (415) 353-2889 our Department in 2019. From a new blood test for concussion to the first neurosurgery.ucsf.edu demonstration of synthetic speech, there are fascinating stories from every 31 Pain and Peripheral Nerve subspecialty of neurosurgery. Disorders UCSF has also again been ranked in the top three neurosurgery and © The Regents of the University neurology programs in the nation – and best on the West Coast – by U.S. 32 Movement Disorders of California News & World Report’s 2019-20 survey of Best Hospitals, reflecting the Executive Editor: Ilona Garner outstanding dedication of our faculty and staff. 36 Pediatric Neurosurgery Writer: Andrew Schwartz UCSF adult and pediatric neurosurgery clinics are available in Marin, Napa and Oakland to provide easy coordination with local physicians and convenient Illustration: Kenneth Xavier Probst 40 Epilepsy access for patients in those areas. Our spine specialists are also available to Design: Victoria Maier Magbilang, see patients at the new Berkeley Outpatient Center – a collaboration between Aqua Design Studio UCSF and John Muir Health. 44 Center for Neural Engineering and Prostheses As always, thank you for allowing us to partner with you in the care of your patients. 46 Community Extension Mitchel S. Berger, MD Professor and Chair Department of Neurological Surgery Berthold and Belle N. Guggenhime Endowed Chair Director, Brain Tumor Center Brain Tumor Center Steady Success in Identifying Genetic Drivers of Brain Tumors Neuropathologist and molecular says Solomon, whose research ensuring the most accurate diagnosis fundamental mechanisms by which neuro-oncologist David Solomon, laboratory investigates the molecular while also identifying potentially cancer develops and escapes MD, PhD, is UCSF Health’s director pathogenesis of human brain tumors. targetable mutations in the tumor standard treatment regimens, which of Molecular Neuropathology, Solomon points out that the and uncovering any type of germ-line will allow us to come up with new responsible for all genomic testing UCSF500 next-generation mutation associated with increased and better therapies,” says Solomon. performed on brain and spinal cord cancer risk. sequencing panel, which he oversees Solomon’s dedication to classifying tumors at UCSF Medical Center. His and which is one of the world’s At the same time, the research and deciphering the molecular basis efforts have been instrumental in leading targeted panels for brain continues on multiple fronts. of the many distinct brain tumor facilitating a molecularly integrated tumor diagnosis and therapy, has led Solomon’s lab recently published an entities – including in the last year diagnostic scheme and enabling a to multiple precision medicine trials. article in Nature Communications chordoid glioma, ganglioglioma, spinal precision medicine approach for the that explains how the STAG2 gene cord diffuse gliomas and radiation- treatment of neuro-oncology patients. In one of these trials, clinicians analyze resected tumors using the – which is commonly mutated in induced gliomas – has led to his being “We hope that if we can determine UCSF500 panel, and a molecular several human cancer types – plays part of the scientific team working to the genetic alterations that are tumor board will decide upon an essential role in DNA replication, update the World Health Organization responsible for driving the different the best personalized targeted thus revealing new potential (WHO)’s Classification of Tumors of brain tumor types – as well as the therapies, with a particular focus on mechanisms for therapeutically the Central Nervous System. cellular pathways that these genetic combination therapies. targeting those glioblastomas alterations deregulate to fuel tumor harboring STAG2 mutations. In fact, today the UCSF500 panel is development – we can intervene with “This work not only helps individual highly specific targeted therapies,” now used to study the vast majority of brain tumors resected at UCSF, patients, but it also builds our knowledge base about the STAG2 is one of the most commonly mutated genes in (left to right) glioblastoma, bladder cancer, and Ewing sarcoma. Mondal G, Stevers M, Goode B, creates a targetable synthetic lethality in Ashworth A, Solomon DA. A requirement cohesin-mutant cancers. Nat Commun. for STAG2 in replication fork progression 2019;10(1):1686. 3 Precision Medicine Trial Offers Individualized Therapy Based on Tumor Genetics In 2019, UCSF neuro-oncologist Repurposing existing drugs is one While the team is using the Jennifer Clarke, MD, initiated a pilot way to more quickly offer alternative Clinical Laboratory Improvement precision medicine trial for adult therapies to patients with life-limiting Amendments (CLIA)-approved patients with recurrent glioblastoma. illness who may not be eligible for UCSF500 next-generation In the trial, 15 eligible participants other clinical trials. A previous pilot sequencing panel to create the undergo surgery as part of their study in 2014, run through the Ivy profile and determine treatment, standard of care, with tumor tissue Foundation Early Phase Clinical when adequate tissue is collected for sequencing aimed Trials Consortium, demonstrated available, patients’ tumors will at determining each tumor’s gene the feasibility of making the also undergo whole-genome expression profile. A multidisciplinary recommendation in a timely fashion and RNA sequencing to assess genomic tumor board reviews the but did not provide the actual drugs whether this would change profile and looks for FDA-approved for treatment. treatment recommendations. In drugs to determine any that may “With this new trial, we are addition, patients’ tumor cells will target the abnormalities found in the excited to actually implement be cultured and inoculated into patient’s tumors, such as overactive the individualized treatments, to organoids to generate patient- tyrosine kinases or growth factors. start to assess the efficacy of this specific models for further testing. The tumor board then recommends approach,” says Clarke. an individualized regimen of up to four FDA-approved drugs. 4 Robust Clinical Trials Program Continues Its Growth The world-renowned clinical trials program at the UCSF Brain Tumor Center more accurate characterization of tumor burden and response to treatment. continues to grow, offering an increasing array of promising treatment options Such projects keep UCSF at the forefront of advancing understanding of how for nearly any brain tumor patient, at any point in their cancer journey. to effectively treat and eventually cure brain cancers. “Our trials cover the spectrum,” says Susan Chang, MD, director of the “The synergy and collaborations among our basic scientists and clinicians Division of Neuro-Oncology. “We have options for newly diagnosed or help us accelerate the development of exciting new treatments for our recurrent tumors, low-grade or high-grade tumors, as well as window-of- patients,” says Chang. opportunity studies when a promising treatment modality becomes available.” Among the most exciting: The center’s innovative approaches to forging connections between its • UCSF is one of only a few institutions offering a clinical trial of personalized clinical trials and basic research has helped it secure game-changing grants, treatment vaccines for low-grade glioma in adults, as well as pediatric gliomas including a P01 Program Project grant from the NIH that was renewed like diffuse instrinsic pontine glioma (DIPG), as noted below. in 2019. “Noninvasive Metabolic Signatures to Improve Management of Molecular Subtypes of Glioma” consists of four integrated and synergistic • The clinical trials program offers a number of immunotherapies that involve projects and two cores, with the overall goal of identifying metabolic engineered viruses or DNA plasmids, including oncolytic virus therapies. One signatures associated with subgroups of glioma defined by various molecular of these oncolytic virus trials is testing a modified poliovirus directed against characteristics. The plan is to integrate these signatures with multiparameter recurrent glioblastoma. Other trials are assessing treatments for glioma, DIPG, imaging strategies that assess spatial and temporal changes in individual medulloblastoma and atypical teratoid/rhabdoid tumor (AT/RT) in children. patients during the course of their disease. The hope is that this will provide a • There are several ongoing clinical trials investigating the use of immune checkpoint inhibitors, either alone or in combination with other therapies like radiation. “The synergy and collaborations among our basic scientists and clinicians help us accelerate the development of exciting new treatments for our patients.” - Susan Chang, MD 5 6 UCSF Researchers Awarded Competitive Grant to Fund Immunotherapy Studies This year, Brain Tumor Center researchers Joseph Costello, PhD; Hideho found using single-sample analysis and, the researchers hope, will facilitate Okada, MD, PhD; and Aaron Diaz, PhD, were awarded Brain Tumor Funders’
Load more

Recommended publications
  • Surgery Guidelines Infection Prevention
    SURGERY GUIDELINES SURGICAL SITE INFECTION: REDUCING YOUR RISK A surgical site infection is a Stanford Hospital & Clinics is committed to implementing strategies to improve risk with any type of surgery. surgical care and to reduce the risk of You can take steps to reduce surgical site infections. your risk of surgical site We want your surgical experience at Stanford Hospital & Clinics to be positive. infection and complications. That experience includes educational • Talk with your healthcare provider materials that describe the process of your about your risk of infection and review surgery and the measures we take to ensure your safety. It is especially important to steps you can take to reduce your reduce the risk of infection. risk prior to the procedure. These are general guidelines. You will • Know the signs and symptoms be provided with more specific instructions of surgical site infection. related to your surgery before your discharge from the hospital. • Know how to reduce your risk while you are in the hospital. INFECTION PREVENTION stanfordhospital.org stanfordhospital.org PRIOR TO DAY OF AFTER SURGERY SURGERY SURGERY KEY POINTS HEALTHCARE TEAMS’ ROLE IN PREVENTION After your surgery and hospital stay, it is Tell your healthcare provider about other • Your surgeon may use electric clippers to important to watch for any changes in your medical problems you may have. Factors remove some of your hair before surgery. symptoms. Call your physician immediately or such as diabetes, obesity, smoking and some • Your surgical team will apply a skin antiseptic go to the nearest emergency room if you are medications could affect your surgery and immediately before the surgery experiencing any of the following symptoms: your treatment.
    [Show full text]
  • 2002-03 Budget for Current Operations and Extramurally Funded Operations (Table)
    2002 2003 Budget for Current Operations UNIVERSITY OF CALIFORNIA Office of the President November 2001 The President’s Message Just one year ago, California enjoyed near-record prosperity and an optimistic view of its future. Today the state faces a major economic slowdown and the unresolved menace of international terrorism. The world has suddenly become a much less certain place for individuals and institutions alike. Yet if there is one thing the current climate of uncertainty and risk makes dramatically clear, it is that research universities are indispensable to solving the nation’s most pressing problems, especially the threats of the new world in which we find ourselves. University of California engineers are already at work on technology that will make future high-rise buildings less vulnerable to terrorist attacks. Experts in bioterrorism are exploring ways to detect toxic substances and remove them from our air and water. Specialists in cybersecurity are investigating threats to communications networks that might develop in the next five to ten years and countermeasures to defend those networks. This is in addition to the daily discoveries and innovations that help make California, in the words of Federal Reserve Chairman Alan Greenspan, “preeminent in transforming knowledge into economic value.” And this does not take into account the outstanding education we give our students across the UC System and the remarkable variety of public service we offer California’s citizens. Given the reality of the State’s fiscal situation, we will have difficult choices to make in the year ahead. But most economists believe that the major fiscal problems of the State are short-term in nature, a perspective that should guide our decision-making as we weigh priorities.
    [Show full text]
  • Medications to Avoid Before Surgery
    ENTRUST MEDICAL GROUP Pre‐operative Information Medications to Avoid Before Surgery It is important to avoid certain medications prior to surgery. The following medications can have effects on bleeding, swelling, increase the risk of blood clots, and cause other problems if taken around the time of surgery. Please notify your surgeon’s office if you are taking any vitamins, herbal medications/supplements as these can also cause problems during your surgery and should not be taken for the two week period before surgery and one week after surgery. It is extremely important that if you come down with a cold, fever, rash, or “any new” medical problem close to your surgery date, you should notify your surgeon’s office immediately. Section One: The following drugs contain aspirin and/or aspirin like effects that may affect your surgery (abnormal bleeding and bruising). These drugs should be avoided for at least two weeks prior to surgery. A.P.C. Doloprin Nuprin A.S.A. Easprin Orudis A.S.A. Enseals Ecotrin Pabalate‐SF Advil Emprin with Codeine Pamelor Aleve Endep Parnate Alka‐Seltzer Plus Equagesic Tablets Percodan Alka‐Seltzer Etrafon Pepto‐Bismol (all types) Anacin Excedrin Persantine Anaprox Feldene Phenteramine Ansaid Fiorinal Phenylbutzone Argesic Flagly Ponstel Arthritis pain formula Four Way Cold Tablets Propoxyphene Compound Arthritis strength Bufferin Gemnisyn Robaxisal Arthropan Liquid Gleprin Rufen AS.A. Goody’s S‐A‐C Ascriptin Ibuprofen (all types) Saleto Asperbuf Indocin Salocol Aspergum Indomethacin Sine‐Aid/Sine‐Off/Sinutab Aspirin (all brands) Lanorinal SK‐65 Compound Atromid Lioresal St. Joseph’s Cold Tab B.C.
    [Show full text]
  • UCSF Fact Sheet
    About UCSF University of California, San Francisco is the leading university exclusively focused on health. Through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in care delivery, UCSF is leading revolutions in health worldwide. UCSF Health was one of the first U.S. hospitals to provide care for patients with COVID-19 and played a significant role in the public health response in collaboration with the City and State, as well as in research into testing, transmission prevention and care protocols and working in our communities throughout the pandemic. UCSF Chancellor Health Care Sam Hawgood, MBBS, a renowned Q UCSF Health is recognized worldwide researcher, professor, academic leader for its innovative, patient-centered care, and pediatrician, has been Chancellor informed by pioneering research and of UCSF since 2014. advanced technologies. Recognized for his strong leadership as UCSF Medical Center ranks among the top 10 hospitals nationwide dean of UCSF School of Medicine from for the care it provides and is among the leading medical centers 2009 to 2014 and brief tenure as interim across all 15 specialties ranked by U.S. News & World Report. It is Chancellor, Hawgood was selected renowned for innovative care in cancer, neurology and neurosurgery, after a national search as UCSF’s 10th cardiology and cardiac surgery, otolaryngology, transplant, chancellor. He reports to UC President .JDIBFM7%SBLF .% and ophthalmology, pulmonology, and urology, among others. UIFUC Board of Regents. With more than 1,700 clinical trials each year, UCSF Health is at Today, Hawgood, the Arthur and Toni Rembe Rock Distinguished the forefront in offering patients the latest therapies, led by clinician Professor at UCSF, oversees a UCSF enterprise, which # researchers who are committed to providing the most advanced care includes the top public recipient of research funds from the in their fields.
    [Show full text]
  • Organ Transplant Discrimination Against People with Disabilities Part of the Bioethics and Disability Series
    Organ Transplant Discrimination Against People with Disabilities Part of the Bioethics and Disability Series National Council on Disability September 25, 2019 National Council on Disability (NCD) 1331 F Street NW, Suite 850 Washington, DC 20004 Organ Transplant Discrimination Against People with Disabilities: Part of the Bioethics and Disability Series National Council on Disability, September 25, 2019 This report is also available in alternative formats. Please visit the National Council on Disability (NCD) website (www.ncd.gov) or contact NCD to request an alternative format using the following information: [email protected] Email 202-272-2004 Voice 202-272-2022 Fax The views contained in this report do not necessarily represent those of the Administration, as this and all NCD documents are not subject to the A-19 Executive Branch review process. National Council on Disability An independent federal agency making recommendations to the President and Congress to enhance the quality of life for all Americans with disabilities and their families. Letter of Transmittal September 25, 2019 The President The White House Washington, DC 20500 Dear Mr. President, On behalf of the National Council on Disability (NCD), I am pleased to submit Organ Transplants and Discrimination Against People with Disabilities, part of a five-report series on the intersection of disability and bioethics. This report, and the others in the series, focuses on how the historical and continued devaluation of the lives of people with disabilities by the medical community, legislators, researchers, and even health economists, perpetuates unequal access to medical care, including life- saving care. Organ transplants save lives. But for far too long, people with disabilities have been denied organ transplants as a result of unfounded assumptions about their quality of life and misconceptions about their ability to comply with post-operative care.
    [Show full text]
  • Medical Centers Report
    Attachment 5 Medical Centers Report 18/19 UC Health is committed to nothing less than the well-being of all Californians. As one of the nation’s largest academic health systems, we combine teaching, research and public service to provide high quality care to millions of patients each year and to drive the medical advances that save lives. UNIVERSITY OF CALIFORNIA Medical Centers 18/19 Annual Financial Report TABLE OF CONTENTS 3 Letter from the Executive Vice President Medical Centers 4 The University of California, Davis Medical Center 8 The University of California, Irvine Medical Center 12 The University of California, Los Angeles Medical Center 16 The University of California, San Diego Medical Center 20 The University of California, San Francisco Medical Center and Children’s Hospital and Research Center Oakland 26 Management’s Discussion and Analysis 52 Report of Independent Auditors Financial Statements, University of California Medical Centers 54 Statements of Net Position 56 Statements of Revenues, Expenses and Changes in Net Position 58 Statements of Cash Flows 62 Notes to Financial Statements 110 Required Supplementary Information 116 University of California Regents and Officers 2 Letter from the Executive Vice President This is my last annual report letter as Executive Vice President • Our payor mix demonstrates our unwavering commitment of UC Health. to caring for all Californians regardless of ability to pay. Despite representing less than six percent of the acute After 50 years in Medicine and 11 years with the University care hospital beds in California, we are one of the largest of California, it is time for me to turn the reins of leadership for providers of inpatient services and hospital-based outpatient UC Health to another.
    [Show full text]
  • Phone Directory
    Phone Directory MAIN PHONE NUMBERS UCSF Medical Center at Mission Bay . (415)353-3000 UCSF Medical Center at Mount Zion . .(415) 567-6600 UCSF Medical Center at Parnassus . (415)476-1000 LOCATION KEY GMB UCSF Ron Conway Family Gateway Medical Building WCH UCSF Betty Irene Moore Women’s Hospital and UCSF Bakar Cancer Hospital BCH UCSF Benioff Children’s Hospital DEPARTMENT . LOCATION . PHONE* Admitting - Adult . WCH 1.476-1099 Blood Bank . .GMB 2.476-1404 Case Management - Adult (Main offi ce) . 514-3742 Case Management - Children’s (Main offi ce) . .353-2278 Central Patient Placement - Adult . .353-1937 Child Life Services (Main offi ce) . BCH 5 & 6 . .353-1203 Child Life Manager . .353-8500 Marie Wattis School Program . BCH 6 . 353-1310 Child Life Playground . BCH 5 . .353-1221 Center for Families . BCH 6 .353-1410 Clinical Lab . GMB2.353-1667 Blood Gas . .514-2146 Gift Shop . .BCH1476-1150 Infection Control . .353-4343 Interpreting Services . .GMB 1 .353-2690 IP3 . .WCH4353-1328 Information Desk - Adult . WCH 1 . .476-1540 Neurodiagnostics . BCH 5 .514-4177 Nursing Administration . BCH 1 . .476-1592 Nutrition and Food Services . WCH 1 . .476-1085 Room Service . .353-1111 *All phone numbers are in area code 415 DEPARTMENT ......................... LOCATION .... PHONE* Occupational Health & Safety . BCH 1 . 885-7580 Needlestick Exposure 24 Hour Number . .353-STIC (7842) Parking and Transportation . 476-1511 Pathology . GMB 2 . 353-1613 Patient Relations . BCH 1 . 353-1936 Patient Access - Children’s . BCH 1 . 353-1611 Pediatric Echocardiography . GMB 6 . 476-3774 Pediatric Pulmonary Function Lab . GMB 6 . 476-3774 Pediatric Stress Lab/EKG .
    [Show full text]
  • UCSF Medical Centre
    UCSF Medical Center, Radiology Laboratory for Radiological Informatics Sun Enterprise™ Servers and DISC's NearLine Storage at the Core of UCSF Radiology's digital image system. As part of University of California San Francisco, UCSF Radiology Center is a leading academic health science campus. Known for its innovative research, outstanding education, and clinical excellence, UCSF Radiology is consistently ranked among the top six institutions in the National Institutes of Health (NIH). Located in Northern California, UCSF Radiology is both a medical school and working hospital. First opening its doors in 1906, UCSF Radiology performs more than 250,000 exams per year. Recently, UCSF Radiology upgraded its Picture, Archive, and Communication System (PACS). The PACS at UCSF incorporates the radiology and hospital information systems to create an intelligent, integrated patient system. At the core of the PACS are Sun Enterprise™ servers running Agfa Impax software and DISC NearLine Storage Systems. The DISC & Sun solution UCSF Radiology’s goal is to always have timely access to digital imagery and patient information. In order to interconnect its database, digital voice dictation system, electronic mail, library information system, and various medical centers, UCSF Radiology needed an open architecture and standardized computer network. DISC & Sun have been providing leading-edge technology to the medical imaging industry for more than a decade. So it’s no wonder UCSF Radiology selected them for the core of its infrastructure. “I’ve been working with DISC & Sun systems for more than 11 years.Together, DISC & Sun consistently have strong products that work well in clinically intensive environments. We do a lot of UNIX® tasks, and our core systems need to have multiprocessing and multithreading capabilities.
    [Show full text]
  • Community Benefit Report June 30, 2016
    Community Benefit Report June 30, 2016 Redefining Possible Report on the community benefit contributions provided by UCSF Health (Medical Center). Includes a strategic implementation plan based on the health priorities determined in the SF County Community Needs Assessment. Table of Contents I. UCSF Health Overview ......................................... 2 V. Psychosocial Health ............................................ 18 II. Community Benefit Planning Process ................... 6 Child & Adolescent Services ............................................ 19 Clinical and Translational Science Institute (CTSI) ....... 6 Citywide Initiatives ........................................................... 19 Center for Community Engagement .............................. 6 HEARTS ............................................................................. 20 Community Health Needs Assessment ............................ 7 Roadmap to Peace ............................................................ 20 UCSF Health Community Benefit Contribution ......... 9 Alcohol Policy Partnership Working Group................. 20 III. Access to Care ..................................................... 10 VI. Nutrition & Activity ............................................ 21 Cancer Screenings ............................................................10 PlaySafe ................................................................................ 21 Skilled Nursing Home Support Program ....................10 SportSmarts ........................................................................
    [Show full text]
  • Medical Terminology Abbreviations Medical Terminology Abbreviations
    34 MEDICAL TERMINOLOGY ABBREVIATIONS MEDICAL TERMINOLOGY ABBREVIATIONS The following list contains some of the most common abbreviations found in medical records. Please note that in medical terminology, the capitalization of letters bears significance as to the meaning of certain terms, and is often used to distinguish terms with similar acronyms. @—at A & P—anatomy and physiology ab—abortion abd—abdominal ABG—arterial blood gas a.c.—before meals ac & cl—acetest and clinitest ACLS—advanced cardiac life support AD—right ear ADL—activities of daily living ad lib—as desired adm—admission afeb—afebrile, no fever AFB—acid-fast bacillus AKA—above the knee alb—albumin alt dieb—alternate days (every other day) am—morning AMA—against medical advice amal—amalgam amb—ambulate, walk AMI—acute myocardial infarction amt—amount ANS—automatic nervous system ant—anterior AOx3—alert and oriented to person, time, and place Ap—apical AP—apical pulse approx—approximately aq—aqueous ARDS—acute respiratory distress syndrome AS—left ear ASA—aspirin asap (ASAP)—as soon as possible as tol—as tolerated ATD—admission, transfer, discharge AU—both ears Ax—axillary BE—barium enema bid—twice a day bil, bilateral—both sides BK—below knee BKA—below the knee amputation bl—blood bl wk—blood work BLS—basic life support BM—bowel movement BOW—bag of waters B/P—blood pressure bpm—beats per minute BR—bed rest MEDICAL TERMINOLOGY ABBREVIATIONS 35 BRP—bathroom privileges BS—breath sounds BSI—body substance isolation BSO—bilateral salpingo-oophorectomy BUN—blood, urea, nitrogen
    [Show full text]
  • Regulation 4 —Pharmacy
    Agency # 070.00 REGULATION 4 —PHARMACY 04-00: GENERAL REGULATIONS REGARDING PHARMACIES 04-00-0001—EQUIPMENT SPECIFICATIONS Prescription equipment appropriate for the pharmacy’s specific scope of practice shall be maintained by the pharmacy and may include but is not limited to: (a) Graduates capable of measuring from 0.1ml to at least 120ml (b) Mortars and pestles--at least one (porcelain or glass) (c) Hot and cold running water in the prescription department (d) Spatulas (e) Ointment slab or ointment papers (f) Exempt narcotic record book (g) Class III balance and weights or comparable electronic scale (h) Equipment for labeling (i) Refrigeration for the proper storage of biologicals and other medications. Medications shall be stored in a separate compartment or area from food. Each pharmacy shall maintain a pharmacy library: (1) available for use by the pharmacist and the patient, including either current drug information manuals, or computers capable of printing current drug information for the pharmacist and patient drug information and monographs for patients. (2) other pharmacy reference books and periodicals necessary for effective pharmacy practice. EXCEPTIONS: Pharmacies meeting the requirements of regulation 04-02-0100 or regulation 07-02-0001 shall be exempt from requirements of this regulation when not applicable. (10/09/80, Revised 6/25/83, 4/07/89, 6/07/90, 8/20/97, 11/1/2007 and 11/6/2008) 04-00-0002—TIME REQUIRMENTS FOR PHARMACIES AND FOR THE PHARMACIST IN CHARGE (a) Unless expressly provided otherwise in Board regulations, all pharmacies in Arkansas shall be open a minimum of forty (40) hours per week and have on duty an Arkansas licensed pharmacist in charge.
    [Show full text]
  • UCSF Neurosurgery News
    UCSF Neurosurgery News UCSF Department of Neurological Surgery Volume 16 Surgical Simulation Lab Drives Innovation for Skull Base and Cerebrovascular Disorders Skull base and cerebrovascular surgery are ranked relatively new field of minimally invasive skull base surgery, among the most difficult of the surgical subspecialties. which involves the use of an endoscope to navigate tiny Neurosurgeons must create corridors through tiny corridors through the nasal passages and sinuses. spaces between nerves, arteries and bone to access At UCSF Medical Center, head and neck surgeons and tumors and vascular lesions. Successfully navigating neurosurgeons often operate together on the same these critical structures requires a masterful grasp of patient, combining expertise on navigating both the neuroanatomy. sinuses and brain tissue. In the past, many lesions of “As a surgeon you cannot always rely on technology,” the skull base were considered inoperable or could only says Roberto Rodriguez Rubio, MD, director of UCSF’s be accessed through large, transfacial operations that Skull Base and Cerebrovascular Laboratory (SBCVL). left patients with significant disfigurement and morbidity. “If you do, you might miss something that could result But over the last decade, routes through the endonasal in a neurological deficit for your patient.” corridor to the clivus, infratemporal fossa, foramen In creating new anatomical models and surgical magnum, paranasal sinuses and intracranial lesions simulations, the SBCVL is currently at the forefront have all been described. of developing minimally invasive routes to complex In the realm of cerebrovascular disorders, Adib Abla, disorders and creating an entirely new way for students, MD, chief of vascular neurosurgery, describes how residents and faculty to experience the relationship anatomic dissections are revealing less invasive between different structures in the brain.
    [Show full text]